These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23541566)

  • 21. The burden of rare cancers in Europe.
    Gatta G; Capocaccia R; Trama A; Martínez-García C;
    Adv Exp Med Biol; 2010; 686():285-303. PubMed ID: 20824452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.
    Dasari A; Shen C; Halperin D; Zhao B; Zhou S; Xu Y; Shih T; Yao JC
    JAMA Oncol; 2017 Oct; 3(10):1335-1342. PubMed ID: 28448665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and relative survival of pancreatic adenocarcinoma and pancreatic neuroendocrine neoplasms in Germany, 2009-2018. An in-depth analysis of two population-based cancer registries.
    Stang A; Wellmann I; Holleczek B; Fell B; Terner S; Lutz MP; Kajüter H
    Cancer Epidemiol; 2022 Aug; 79():102204. PubMed ID: 35777306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The epidemiology of neuroendocrine tumors in Taiwan: a nation-wide cancer registry-based study.
    Tsai HJ; Wu CC; Tsai CR; Lin SF; Chen LT; Chang JS
    PLoS One; 2013; 8(4):e62487. PubMed ID: 23614051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Second cancers in patients with neuroendocrine tumors.
    Tsai HJ; Wu CC; Tsai CR; Lin SF; Chen LT; Chang JS
    PLoS One; 2013; 8(12):e86414. PubMed ID: 24392036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endocrine tumours: epidemiology of malignant digestive neuroendocrine tumours.
    Lepage C; Bouvier AM; Faivre J
    Eur J Endocrinol; 2013 Apr; 168(4):R77-83. PubMed ID: 23349330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Childhood neuroendocrine tumours: a descriptive study revealing clues for genetic predisposition.
    Diets IJ; Nagtegaal ID; Loeffen J; de Blaauw I; Waanders E; Hoogerbrugge N; Jongmans MC
    Br J Cancer; 2017 Jan; 116(2):163-168. PubMed ID: 27959889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignant neuroendocrine tumors: incidence and outcomes in pediatric patients.
    Allan B; Davis J; Perez E; Lew J; Sola J
    Eur J Pediatr Surg; 2013 Oct; 23(5):394-9. PubMed ID: 23444065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and survival of rare urogenital cancers in Europe.
    Visser O; Adolfsson J; Rossi S; Verne J; Gatta G; Maffezzini M; Franks KN;
    Eur J Cancer; 2012 Mar; 48(4):456-64. PubMed ID: 22119351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence, survival and prevalence of myeloid malignancies in Europe.
    Visser O; Trama A; Maynadié M; Stiller C; Marcos-Gragera R; De Angelis R; Mallone S; Tereanu C; Allemani C; Ricardi U; Schouten HC;
    Eur J Cancer; 2012 Nov; 48(17):3257-66. PubMed ID: 22770878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan.
    Ito T; Sasano H; Tanaka M; Osamura RY; Sasaki I; Kimura W; Takano K; Obara T; Ishibashi M; Nakao K; Doi R; Shimatsu A; Nishida T; Komoto I; Hirata Y; Nakamura K; Igarashi H; Jensen RT; Wiedenmann B; Imamura M
    J Gastroenterol; 2010 Feb; 45(2):234-43. PubMed ID: 20058030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An overview of the current diagnosis and recent developments in neuroendocrine tumours of the gastroenteropancreatic tract: the diagnostic approach.
    Kuiper P; Verspaget HW; Overbeek LI; Biemond I; Lamers CB
    Neth J Med; 2011 Jan; 69(1):14-20. PubMed ID: 21325696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Data quality in rare cancers registration: the report of the RARECARE data quality study.
    Trama A; Marcos-Gragera R; Sánchez Pérez MJ; van der Zwan JM; Ardanaz E; Bouchardy C; Melchor JM; Martinez C; Capocaccia R; Vicentini M; Siesling S; Gatta G;
    Tumori; 2017 Jan; 103(1):22-32. PubMed ID: 27716878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Descriptive epidemiological study of rare, less common and common cancers in Western Australia.
    Bilkey GA; Trevithick RW; Coles EP; Girschik J; Nowak KJ
    BMC Cancer; 2021 Jul; 21(1):779. PubMed ID: 34233636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distribution, incidence, and prognosis in neuroendocrine tumors: a population based study from a cancer registry.
    Caldarella A; Crocetti E; Paci E
    Pathol Oncol Res; 2011 Sep; 17(3):759-63. PubMed ID: 21476126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].
    Zona A; Fazzo L; Benedetti M; Bruno C; Vecchi S; Pasetto R; Minichilli F; De Santis M; Nannavecchia AM; Di Fonzo D; Contiero P; Ricci P; Bisceglia L; Manno V; Minelli G; Santoro M; Gorini F; Ancona C; Scondotto S; Soggiu ME; Scaini F; Beccaloni E; Marsili D; Villa MF; Maifredi G; Magoni M; Iavarone I;
    Epidemiol Prev; 2023; 47(1-2 Suppl 1):1-286. PubMed ID: 36825373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A population-based study of outcomes in patients with gastrointestinal neuroendocrine tumours.
    McMullen T; Al-Jahdali A; de Gara C; Ghosh S; McEwan A; Schiller D
    Can J Surg; 2017 Jun; 60(3):192-197. PubMed ID: 28327275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rare cancers in childhood and adolescence in Brazil: First report of data from 19 population-based cancer registries.
    Balmant NV; de Souza Reis R; de Oliveira Santos M; de Camargo B; Gatta G
    Cancer; 2019 Aug; 125(15):2638-2646. PubMed ID: 31013367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence and survival patterns of rare anal canal neoplasms using the surveillance epidemiology and end results registry.
    Metildi C; McLemore EC; Tran T; Chang D; Cosman B; Ramamoorthy SL; Saltzstein SL; Sadler GR
    Am Surg; 2013 Oct; 79(10):1068-74. PubMed ID: 24160801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival from rare cancer in adults: a population-based study.
    Gatta G; Ciccolallo L; Kunkler I; Capocaccia R; Berrino F; Coleman MP; De Angelis R; Faivre J; Lutz JM; Martinez C; Möller T; Sankila R;
    Lancet Oncol; 2006 Feb; 7(2):132-40. PubMed ID: 16455477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.